Trial NCT00047333

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02498
Secondary IDs: CDR0000257665 ID02-008

Last trial update was posted on 2013-01-23

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular Liver Neoplasms

Other Conditions

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID